Partners in Practice Articles

The Central Access Line is Roswell Park’s main number at 716-845-2300, and all public-facing telephone lines flow into this central area.

The National Cancer Institute (NCI) has affirmed its support for Roswell Park Comprehensive Cancer Center, renewing its status as one of 50 elite Comprehensive Cancer Centers and awarding a $22.5 million Cancer Center Support Grant to fund core research and education programs — the largest such a

Roswell Park Comprehensive Cancer Center joined with hospitals, health systems, physicians and supportive care teams from across the state, all committed to reducing the burden of cancer, to launch the Roswell Park Care Network.

Beginning in August 2019, the Roswell Park Care Network Southtowns medical oncology/hematology practice will move to 3041 Orchard Park Road in Orchard Park.

There are 128,000 cancer survivors in Western New York and many of these individuals must continue their surveillance after they have received a clean bill of health.

Roswell Park Comprehensive Cancer Center is growing, and with that growth we’ve had to make many internal changes to meet the expectations of your patients. We’ve added services, crucial support staff and expertise in key areas.

The past 10 years have led to significant improvements in assessing hereditary cancer risk, due largely to advancements in genetic testing technology, knowledge of hereditary cancer risks and the identification of new cancer-associated genes.

Gastric adenocarcinoma commonly spreads through carcinomatosis or peritoneal metastases (PM). This was often discovered at the time of attempted curative gastric resection, given the poor ability of preoperative staging CT scans to detect the presence and extent of PM. In patients where visible PMs are absent, diagnostic laparoscopy with peritoneal lavage and cytology has been shown to be an effective method of noting free intraperitoneal tumor cells. This is also defined as M1 disease and is generally associated with T3 or T4 primary gastric cancers.
There has been significant debate over the use of minimally invasive resection for the management of advanced gastric cancer. Laparoscopic surgery appears as a favorable approach, given the previously reported decrease in postoperative pain, pulmonary complications, and hospital lengths of stay. The reluctance to widely adopt this technique centers on concerns about its oncologic completeness and the complexity of the procedure.

by Renuka Iyer, MD

To prepare for the second annual Roswell Park Cancer Institute (RPCI) patient seminar on neuroendocrine cancer on October 18, 2014, I sat down to think about the progress made in this field.

by Smit Singla, MD, MRCSEd, MSc, and Boris Kuvshinoff, MD, MBA

Neuroendocrine tumors (NET) are a group of relatively slow-growing tumors that arise mostly in the pulmonary and gastrointestinal system. Considered rare, their incidence has increased 6.3% in the last 25 years, with a prevalence of 35 per 100,000 patients. Because patients with these tumors generally present with vague symptoms, the diagnosis is often delayed by five to seven years.

by Steven Hochwald, MD

There are several ways to remove the adrenal gland. For many years the minimally invasive transperitoneal approach has been the preferred technique and is now used more than any other. Yet it has limitations, including painful and unsightly incisions on the anterior abdominal wall.